Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 0

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box:

| ☐ | Preliminary Proxy Statement |

| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 
 14a-6(e)(2))                                                       |

| ☒ | Definitive Proxy Statement |

| ☐ | Definitive Additional Materials |

| ☐ | Soliciting Material under §240.14a-12 |

AADI BIOSCIENCE, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):

| ☐ | No fee required. |

| ☒ | Fee paid previously with preliminary materials. |

| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 
 14a-6(i)(1) and 0-11.                                                          |

Aadi Bioscience, Inc. 17383 Sunset Boulevard, Suite A250 Pacific Palisades, California 90272 January 31, 2025 To the Stockholders of Aadi Bioscience, Inc.: You are cordially invited to virtually attend a special meeting of stockholders (together with any adjournment or postponement thereof, the “Special Meeting”) of Aadi Bioscience, Inc. (“Aadi,” the “Company,” “we” or “us”), which will be held online on February 28, 2025 at 10:00 am, Pacific Time via webcast at www.virtualshareholdermeeting.com/ AADI2025SM. The Special Meeting will be a completely virtual meeting which will be conducted via live webcast. Details regarding admission to the Special Meeting and the business to be conducted at that time are more fully described in the accompanying Notice of Special Meeting and Proxy Statement. At this Special Meeting, stockholders will be asked to consider and vote on the following proposals:

| 1. | Divestiture Proposal. To approve the sale by Aadi to KAKEN INVESTMENTS INC. (“Kaken”) of 100%                                                                                                                                                     
 of the outstanding shares of capital stock of Aadi Subsidiary, Inc.